164 related articles for article (PubMed ID: 10599635)
21. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
[TBL] [Abstract][Full Text] [Related]
22. Porphyria cutanea tarda and hepatitis C virus infection.
Tsukazaki N; Watanabe M; Irifune H
Br J Dermatol; 1998 Jun; 138(6):1015-7. PubMed ID: 9747364
[TBL] [Abstract][Full Text] [Related]
23. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
Okano J; Horie Y; Kawasaki H; Kondo M
Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
[TBL] [Abstract][Full Text] [Related]
24. Reference intervals for 24-hour and random urine porphyrins.
Nuttall KL; Pingree SS; Ashwood ER
Ann Clin Lab Sci; 1996; 26(4):313-22. PubMed ID: 8800431
[TBL] [Abstract][Full Text] [Related]
25. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
[TBL] [Abstract][Full Text] [Related]
26. On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations.
Zuijderhoudt FM; Koehorst SG; Kluitenberg WE; Dorresteijn-de Bok J
Clin Chem Lab Med; 2000 Mar; 38(3):227-30. PubMed ID: 10905759
[TBL] [Abstract][Full Text] [Related]
27. Porphyria cutanea tarda presenting as cicatricial conjunctivitis.
Park AJ; Webster GF; Penne RB; Raber IM
Am J Ophthalmol; 2002 Oct; 134(4):619-21. PubMed ID: 12383830
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital.
Aguilera P; Laguno M; To-Figueras J
Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):93-7. PubMed ID: 26576928
[TBL] [Abstract][Full Text] [Related]
29. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
30. [Porphyrin metabolic disorders in porphyria cutanea tarda].
Krivosheev BN
Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
[TBL] [Abstract][Full Text] [Related]
31. Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: A case report.
Nihei T; Kiniwa Y; Mikoshiba Y; Joshita S; Okuyama R
J Dermatol; 2019 May; 46(5):e149-e151. PubMed ID: 30506825
[No Abstract] [Full Text] [Related]
32. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
[TBL] [Abstract][Full Text] [Related]
33. Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals.
Sastre L; To-Figueras J; Lens S; Rodriguez-Tajes S; Bartres C; Aguilera P; Badenas C; Oliva R; Pocurull A; Forns X; Mariño Z
Aliment Pharmacol Ther; 2020 May; 51(10):968-973. PubMed ID: 32294804
[TBL] [Abstract][Full Text] [Related]
34. High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda.
Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Pinelli G
Pharmacol Res; 2002 Apr; 45(4):355-9. PubMed ID: 12030801
[TBL] [Abstract][Full Text] [Related]
35. Porphyria cutanea tarda.
Fritsch C; Lang K; von Schmiedeberg S; Bolsen K; Merk H; Lehmann P; Ruzicka T
Skin Pharmacol Appl Skin Physiol; 1998; 11(6):321-35. PubMed ID: 10343203
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
37. Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda.
Nichols RC; Cooper S; Trask HW; Gorman N; Dalton TP; Nebert DW; Sinclair JF; Sinclair PR
Biochem Pharmacol; 2003 Feb; 65(4):545-50. PubMed ID: 12566081
[TBL] [Abstract][Full Text] [Related]
38. Cimetidine in the treatment of porphyria cutanea tarda.
Horie Y; Tanaka K; Okano J; Ohgi N; Kawasaki H; Yamamoto S; Kondo M; Sassa S
Intern Med; 1996 Sep; 35(9):717-9. PubMed ID: 8915698
[TBL] [Abstract][Full Text] [Related]
39. Porphyrin metabolism in hepatitis C infection.
O'Reilly FM; Darby C; Fogarty J; O'Moore R; Courtney MG; O'Connor J; Kay EW; Leader M; Fielding JF; Murphy GM
Photodermatol Photoimmunol Photomed; 1996 Feb; 12(1):31-3. PubMed ID: 8884897
[TBL] [Abstract][Full Text] [Related]
40. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
